Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis

NCT05159050 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Drug supply issues

Conditions

Peritoneal Carcinomatosis

Interventions

DRUG: Paclitaxel-loaded tumor penetrating microparticles

Sponsor

Carlos Chan

Collaborators

Institute of Quantitative Systems Pharmacology (IQSP)